1. World Health Organization (WHO). 2020. WHO coronavirus disease (COVID-19) dashboard. WHO;Geneva: Available from:
https://covid19.who.int/table. cited 2020 Jul 15.
2. Saigal S, Gupta S, Sudhindran S, Goyal N, Rastogi A, Jacob M, et al. 2020; Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the liver transplant Society of India (LTSI). Hepatol Int. 14:429–431. DOI:
10.1007/s12072-020-10041-1. PMID:
32270388. PMCID:
PMC7140588.

3. Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM, Mulligan DC, et al. 2020; Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pandemic: AASLD expert panel consensus statement. Hepatology. 72:287–304. DOI:
10.1002/hep.31281. PMID:
32298473. PMCID:
PMC7262242.

4. Qin J, Wang H, Qin X, Zhang P, Zhu L, Cai J, et al. 2020; Perioperative presentation of COVID-19 disease in a liver transplant recipient. Hepatology. doi: 10.1002/hep.31257. [in press]. DOI:
10.1002/hep.31257. PMID:
32220017.
5. Pereira MR, Mohan S, Cohen DJ, Husain SA, Dube GK, Ratner LE, et al. 2020; COVID-19 in solid organ transplant recipients: initial report from the US epicenter. Am J Transplant. 20:1800–1808. DOI:
10.1111/ajt.15941. PMID:
32330343. PMCID:
PMC7264777.

6. Hammami MB, Garibaldi B, Shah P, Liu G, Jain T, Chen PH, et al. 2020; Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: a case report. Am J Transplant. 20:2254–2259. DOI:
10.1111/ajt.15985. PMID:
32359210. PMCID:
PMC7267667.

7. Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, et al. 2020; Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 323:1582–1589. DOI:
10.1001/jama.2020.4783. PMID:
32219428. PMCID:
PMC7101507.

8. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. RECOVERY Collaborative Group. 2020; Dexamethasone in hospitalized patients with COVID-19 - preliminary report. N Engl J Med. doi: 10.1056/NEJMoa2021436. [in press]. DOI:
10.1056/NEJMoa2021436. PMID:
32678530. PMCID:
PMC7383595.

9. Tanaka Y, Sato Y, Sasaki T. 2013; Suppression of coronavirus replication by cyclophilin inhibitors. Viruses. 5:1250–1260. DOI:
10.3390/v5051250. PMID:
23698397. PMCID:
PMC3712306.

10. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. 2020; COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 75:2950–2973. DOI:
10.1016/j.jacc.2020.04.031. PMID:
32311448. PMCID:
PMC7164881.
11. Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. 2020; Compassionate use of remdesivir for patients with severe COVID-19. N Engl J Med. 382:2327–2336. DOI:
10.1056/NEJMoa2007016. PMID:
32275812. PMCID:
PMC7169476.
12. Genentech Medical. 2019. Serious risk with use of ACTEMRA
® (tocilizumab). Genentech;South San Francisco: Available from:
https://www.gene.com/download/pdf/. cited 2020 Jul 15.
13. Schmidt-Arras D, Rose-John S. 2016; IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol. 64:1403–1415. DOI:
10.1016/j.jhep.2016.02.004. PMID:
26867490.

14. Liu B, Wang Y, Zhao Y, Shi H, Zeng F, Chen Z. 2020; Successful treatment of severe COVID-19 pneumonia in a liver transplant recipient. Am J Transplant. 20:1891–1895. DOI:
10.1111/ajt.15901. PMID:
32243673.

15. Psaltopoulou T, Sergentanis TN, Pappa V, Politou M, Terpos E, Tsiodras S, et al. 2020; The emerging role of convalescent plasma in the treatment of COVID-19. Hemasphere. 4:e409. DOI:
10.1097/HS9.0000000000000409. PMID:
32647807. PMCID:
PMC7306310.

16. Salazar E, Perez KK, Ashraf M, Chen J, Castillo B, Christensen PA, et al. 2020; Treatment of coronavirus disease 2019 (COVID-19) patients with convalescent plasma. Am J Pathol. 190:1680–1690. DOI:
10.1016/j.ajpath.2020.05.014. PMID:
32473109. PMCID:
PMC7251400.
17. Ye M, Fu D, Ren Y, Wang F, Wang D, Zhang F, et al. 2020; Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. J Med Virol. doi: 10.1002/jmv.25882. [in press]. DOI:
10.1002/jmv.25882. PMID:
32293713. PMCID:
PMC7262027.

18. Jiang J, Miao Y, Zhao Y, Lu X, Zhou P, Zhou X, et al. 2020; Convalescent plasma therapy: helpful treatment of COVID-19 in a kidney transplant recipient presenting with serve clinical manifestation and complex complications. Clin Transplant. doi: 10.1111/ctr.14025. [in press]. DOI:
10.1111/ctr.14025. PMCID:
PMC7361058. PMID:
32602952.
19. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. 2020; Remdesivir for the treatment of COVID-19 - final report. N Engl J Med . doi: 10.1056/NEJMoa2007764. [in press]. DOI:
10.1056/NEJMoa2007764. PMID:
32445440. PMCID:
PMC7262788.

20. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. 2020; Virological assessment of hospitalized patients with COVID-2019. Nature. 581:465–469. DOI:
10.1038/s41586-020-2196-x. PMID:
32235945.
